Moore Capital Management, LP Protagonist Therapeutics, Inc Call Options Transaction History

Moore Capital Management, LP

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2023 Aug 14, 2023	SELL	$18.02 - $29.36 $90,100 - $146,800	-5,000 Reduced 20.0%	20,000 $552,000
Q1 2023 May 15, 2023	BUY	$10.78 - $25.38 $269,500 - $634,500	25,000 New	25,000 $575,000

212

59.1M

19K

107K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.34B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.